MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Global women’s health leader Hologic, Inc. (Nasdaq: HOLX) today announced that its Affirm® Contrast Biopsy Software, which combines contrast-enhanced diagnostic ...
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics stocks, including Hologic (NASDAQ:HOLX) and its peers. The medical devices ...
Hologic HOLX has seen steady gains over the last six months. Shares of this Massachusetts, MA-based medtech firm rose 16.1%, outpacing the industry’s 15% growth and the broader Zacks Medical sector’s ...
MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds ...